SIMRIDARLIMAB

UNII:	0VN2H61ATB
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	SIMRIDARLIMAB
GSRS Full Record:	0VN2H61ATB i

2378862-90-7
IBI 322 [WHO-DD]
IMMUNOGLOBULIN G (298-ALANINE,299-ALANINE,413-CYSTEINE,430-SERINE,432-ALANINE,471-VALINE), ANTI-(HUMAN PROGRAMMED DEATH-LIGAND 1) (HUMANIZED CAMELUSBACTRIANUS MONOCLONAL BI127 SINGLE-DOMAIN VHH FRAGMENT) FUSION PROTEIN WITH PEPTIDE LINKER (GSSS)4 FUSION PROTEIN WITH (HUMANIZED CAMELUSBACTRIANUS MONOCLONAL BI127 SINGLE-DOMAIN VHH FRAGMENT) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (HUMAN .GAMMA.1-CHAIN FC FRAGMENT), (290->224'),(293->227'),(413->352')-TRIS(DISULFIDE) WITH IMMUNOGLOBULIN G1 (232-ALANINE,233-ALANINE,352-CYSTEINE,364-TRYPTOPHAN,DE-C-TERMINAL LYSINE) ANTI-(HUMAN CD47 ANTIGEN) (HUMAN MONOCLONAL ADI29341 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL ADI29341 .KAPPA.-CHAIN
simridarlimab [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

SIMRIDARLIMAB

Synonyms and Mappings

Resources